General Partner, Inc. Novo Nordisk A S Transaction History
General Partner, Inc.
- $166 Billion
- Q4 2024
A detailed history of General Partner, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, General Partner, Inc. holds 880 shares of NVO stock, worth $77,132. This represents 0.05% of its overall portfolio holdings.
Number of Shares
880
Previous 880
-0.0%
Holding current value
$77,132
Previous $105 Million
27.76%
% of portfolio
0.05%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,956Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.77 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.26 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.26 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.17 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.07 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $198B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...